9:00am - 5:00pm

Office Hours Mon. - Fri.


Call Us For Free Consultation



Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

Estimated reading time: < 1 min


Malignant Pleural Mesothelioma

Estimated Enrollment: 40

Age Group: 18 Years to 85 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: MPM phase II Carbo/VNB

Study First Received: January 3, 2006

Last Updated: September 17, 2009

Estimated Primary Completion Date: September 2009

Primary Outcome Measures:


Sponsors and Collaborators:

Rigshospitalet, Denmark

Result Received: No Study Results Posted

Website Link: https://ClinicalTrials.gov/show/NCT00272558

Was this article helpful?
Views: 63